Navigation Links
Nile Therapeutics Reports 2012 Second Quarter Financial Results
Date:8/14/2012

SAN FRANCISCO, Aug. 14, 2012 /PRNewswire/ -- Nile Therapeutics, Inc. (OTCQB: NLTX.PK), a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced its second quarter financial results for 2012. 

For the second quarter of 2012, Nile reported a net operating loss of $0.3 million, or $0.01 per share, compared to a net loss of approximately $0.9 million, or $0.03 per share during the second quarter of 2011. Weighted-average shares outstanding for the quarter were 43 million.

Net cash used in operating activities in the second quarter of 2012 was approximately $0.9 million. As of June 30, 2012, Nile had cash and cash equivalents of $0.8 million compared to $1.0 million as of December 31, 2011.About Nile TherapeuticsNile Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops innovative products for the treatment of cardiovascular disease and other areas of unmet medical needs. Nile is initially focusing its efforts on developing its lead compound, cenderitide, a novel rationally designed chimeric peptide in clinical studies for the treatment of heart failure. More information on Nile can be found at http://www.nilethera.com.

Safe Harbor Paragraph for Forward-Looking Statements: This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding Nile's plans to develop cenderitide in the post-acute setting and the anticipated benefits of cenderitide for patients in the post-acute setting are forward-looking statements. Nile may not actually achieve these plans, intentions or expectations and Nile cautions investors not to place undue reliance on Nile's forward-looking statements. Actual results or events could differ mater
'/>"/>

SOURCE Nile Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Zenobia Therapeutics Announce A Partnership With The Alzheimers Drug Discovery Foundation
2. Elcelyx Therapeutics Names Mark Wiggins Senior Vice President of Business Development, Ginger Graham to Board of Directors
3. Echo Therapeutics Announces Second Quarter 2012 Financial Results
4. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2012
5. Echo Therapeutics Announces $20 Million Financing with Platinum-Montaur Life Sciences
6. Orexigen Therapeutics Reports Financial Results for the Second Quarter Ended June 30, 2012
7. Cempra, Inc. to Present at the NIAID Workshop Bridging the Gap - Overcoming Bottlenecks in the Development of Therapeutics for Infectious Diseases
8. Nile Therapeutics Promotes Darlene Horton, M.D., to Chief Executive Officer and Director
9. Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019
10. Silence Therapeutics - Admission of Shares and Board Update
11. Orexigen Therapeutics Schedules August 7, 2012 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... -- Genoa has acquired West Bend Assisted Living Pharmacy ( ... with a proven track record for excellent service to ... those involved in their care. Both companies have strong ... value to their customers. ... services dedicated to the behavioral health community and those ...
(Date:7/1/2015)... , July 1, 2015   Continental Clinical Solutions (Continental) announced it is ... private practice to accommodate increased volume in clinical studies and demand for unique patient populations.  ... ... ... ...
(Date:7/1/2015)... 2015 Egalet Corporation (Nasdaq: EGLT ... focused on developing, manufacturing and marketing innovative pain ... president and chief executive officer, is scheduled to ... provide an update on Egalet,s marketed product ... approved product OXAYDO ™ (oxycodone HCI, USP) ...
Breaking Medicine Technology:Genoa, a QoL Healthcare Company Acquires West Bend Assisted Living Pharmacy 2Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 2Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 3Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 4Egalet to Present at Upcoming Conferences This Summer 2Egalet to Present at Upcoming Conferences This Summer 3
... address to a conference on Regional Innovation Clusters today, ... Eli Lilly and Company (NYSE: LLY ), ... innovation as a key to renewing the nation,s economy. ... of the Obama administration, at a conference co-hosted by ...
... that a new market research report is available in ... PharmaVitae Profile http://www.reportlinker.com/p0201761/Eli-Lilly--Co-PharmaVitae-Profile.html ... and forecast performance for Eli Lilly in the prescription ... and pipeline analysis and assessment of financial per ...
Cached Medicine Technology:Lilly CEO Says Regional Innovation Clusters Can Renew the Nation's Economy 2Lilly CEO Says Regional Innovation Clusters Can Renew the Nation's Economy 3Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile 2Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile 3Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile 4Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile 5Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile 6Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile 7
(Date:7/1/2015)... ... ... Trevor L. Williams, DMD holds a Bachelor of Science degree in Biomedical Sciences ... in Microbiology. He graduated from the University of Florida College of Dentistry in 2015 ... and the Academy of General Dentistry. Dr. Williams was born in Tampa and is ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... Scoliosis is a disorder in which the ... Scoliosis Foundation, it affects 2 to 3 percent of the population, or an estimated 6 ... often develops in children between the ages of 10 and 15. Most types of scoliosis ...
(Date:7/1/2015)... ... July 01, 2015 , ... Franklin University, one of the leading educators of ... has been named Dean of the College of Health & Public Administration . ... support the vision and mission of Franklin University via curriculum planning, course scheduling, faculty ...
(Date:7/1/2015)... ... 2015 , ... A Priority Setting Partnership put in place ... they hope will guide future mesothelioma research. Surviving Mesothelioma has just posted an ... , More than 450 mesothelioma patients, caregivers, and healthcare professionals answer the mesothelioma ...
(Date:7/1/2015)... ... 2015 , ... Amada Senior Care, premier provider of non-medical in-home care and ... – their Mesa, Arizona location . Amada franchise partners Kris Patmos and Kimberly ... rights to the area after years of experience in the sales and healthcare industries. ...
Breaking Medicine News(10 mins):Health News:Trevor L. Williams, D.M.D. Joins Enlow & Vance Dental Partners in Tampa, Florida 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 3Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 4Health News:Franklin University Appoints Dean of College of Health & Public Administration 2Health News:New Report Identifies Top 10 Mesothelioma Research Priorities, According to Surviving Mesothelioma 2Health News:Amada Senior Care Expands to Greater Phoenix Area 2
... SWEDESBORO, N.J., Oct. 1 Wedgewood Pharmacy ... entered an agency agreement,through which Midwest will ... clinics in 27 states. The relationship is,effective ... that Midwest has represented a,compounding pharmacy service. ...
... Attorneys from McKissock & Hoffman, PHILADELPHIA, Oct. ... Cherin and Mellott, LLC today announced that it ... of 22 attorneys from,McKissock & Hoffman including name ... in the continued expansion of Eckert Seamans, Philadelphia,and ...
... a supplier,of affordable medical imaging systems to healthcare providers, ... president of Sales,and Business Development for the company. ... to the,next level," says Tom Hacking, chairman and chief ... forward to the many contributions he,will make." With ...
... Educational ... Resource at IDSA Annual Meeting, HADDON HEIGHTS, N.J., Oct. ... continuing education,resource as part of their exhibit booth at the ... October 4-7, in San Diego,California. Project CDAD: Outbreak Prevention and ...
... pinch in the arm can help save 36,000 lives ... the,beginning of flu season, which will put up to ... is easily prevented with an inexpensive,vaccination. AARP is urging ... begins its annual spread., (Logo: http://www.newscom.com/cgi-bin/prnh/20070209/NYF043LOGO ...
... 1 BD (Becton,Dickinson and Company) (NYSE: BDX ... of its fourth fiscal quarter 2007 earnings conference call ... will issue a press,release detailing the quarter,s earnings earlier ... will be accessible through BD,s,website at http://www.bd.com/investors ...
Cached Medicine News:Health News:Wedgewood Pharmacy and Midwest Veterinary Supply Sign New Agency Agreement 2Health News:Wedgewood Pharmacy and Midwest Veterinary Supply Sign New Agency Agreement 3Health News:Eckert Seamans Announces Major Expansion in Philadelphia, West Chester and Harrisburg 2Health News:Eckert Seamans Announces Major Expansion in Philadelphia, West Chester and Harrisburg 3Health News:National Experts Team Up to Help Hospitals Prevent and Control C. difficile Outbreaks 2Health News:AARP Reminds All People 50-Plus to Get a Flu Shot This Year 2
200 L, Bulk, yellow Recommended for 20, 25, 50, 100 and 200 L pipettes. Can also be used with 300 L pipettes when pipetting 200 L or less....
Capillary section fits into a 0.3-mm well for accurate loading of sequencing gels...
The Ultra Micro tip for the Eppendorf and Nichiryo/BenchMate 0.5-10 L pipettors is perfect for working with low volume samples....
10 L, Bulk Recommended for 2, 5 and 10 L pipettes....
Medicine Products: